Saladax Biomedical
News Investor Relations Contact Us
Overview Background Company Team Selected Readings
Rapid tests for chemotherapy blood levels

Saladax Biomedical is pioneering the development of novel, fast and
inexpensive immunoassays
that will enable routine blood level monitoring
of anti-cancer drugs to become the standard of care in treating cancer patients.
With Personalized Chemotherapy Management (PCM), oncologists will be able to
adjust the administered dose based on each patient’s individual drug level leading
to reduced toxicity, improved outcome and lower cancer-care costs.

 

Now Available - Analyte Specific Reagents for Busulfan Home Brew Testing.

"Cancer is a personal and life-changing event. We help you live a better life during and after treatment by helping your doctor determine the right dose of your cancer drugs. We don’t make the chemotherapy drugs, we just make them better." - Salvatore J. Salamone, Ph.D., Chairman & Chief Scientific Officer